The World Health Organization refreshed its living guideline for mpox clinical management and infection prevention and control in 2025, aligning recommendations with emerging evidence. Earlier briefings flagged continuing transmission risks and variable vaccine coverage across regions, and WHO has maintained standing recommendations under its emergency procedures.

Why it matters: updated protocols help clinicians and public-health teams manage outbreaks and reduce severe outcomes while global case patterns remain uneven.